Tapewire

NYSE · USD

BFS

SAUL CENTERS, INC.

Export transactions ↓
Tapewire entity
4877
SEC CIK
0000907254
Parsed reports
579

Last 12 months

Inside the activity.

12 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202590
Dec 202500
Jan 202600
Feb 202600
Mar 202610
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202600
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Pearson David ToddDirector · President & COO
GrantCommon Stock 3,500 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000013 · wk-form4_1773350644.xml · nonDerivative · entry 3

Pearson David Todd · CIK 0001804456 · Director · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,118.903

F4 · shares: Represents additional restricted shares of Common Stock earned based on the achievement of performance criteria with respect to a performance period commencing on January 1, 2025 and ending on December 31, 2025. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Pearson David ToddDirector · President & COO
Exercise / conversionCommon Stock 7,000 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000013 · wk-form4_1773350644.xml · nonDerivative · entry 2

Pearson David Todd · CIK 0001804456 · Director · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,618.903

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Represents restricted shares of Common Stock. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

F3 · balance_after: Balance increased by January 31, 2026 Dividend Reinvestment Plan award of 51.987 shares.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Garland Judith K.SVP, Office and Retail
Exercise / conversionPerformance Shares · Derivative 300 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000016 · wk-form4_1773350668.xml · derivative · entry 7

Garland Judith K. · CIK 0001849366 · SVP, Office and Retail

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,200

Underlying: Common Stock · 300 shares

Expires 2030-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Garland Judith K.SVP, Office and Retail
Exercise / conversionPerformance Shares · Derivative 200 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000016 · wk-form4_1773350668.xml · derivative · entry 6

Garland Judith K. · CIK 0001849366 · SVP, Office and Retail

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600

Underlying: Common Stock · 200 shares

Expires 2029-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Garland Judith K.SVP, Office and Retail
GrantCommon Stock 250 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000016 · wk-form4_1773350668.xml · nonDerivative · entry 2

Garland Judith K. · CIK 0001849366 · SVP, Office and Retail

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,489

F2 · shares: Represents additional restricted shares of Common Stock earned based on the achievement of performance criteria with respect to a performance period commencing on January 1, 2025 and ending on December 31, 2025. Of these restricted shares, 100 shares vest on May 17, 2029, and 150 shares vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Garland Judith K.SVP, Office and Retail
Exercise / conversionCommon Stock 500 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000016 · wk-form4_1773350668.xml · nonDerivative · entry 1

Garland Judith K. · CIK 0001849366 · SVP, Office and Retail

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,239

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents restricted shares of Common Stock. Of these restricted shares, 200 shares vest on May 17, 2029, and 300 shares vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Saul Patricia E.Director · Vice Chair
Exercise / conversionPerformance Shares · Derivative 400 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000014 · wk-form4_1773350652.xml · derivative · entry 5

Lotuff Patricia Saul · CIK 0001972629 · Director · Vice Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600

Underlying: Common Stock · 400 shares

Expires 2030-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Saul Patricia E.Director · Vice Chair
Exercise / conversionPerformance Shares · Derivative 400 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000014 · wk-form4_1773350652.xml · derivative · entry 4

Lotuff Patricia Saul · CIK 0001972629 · Director · Vice Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,200

Underlying: Common Stock · 400 shares

Expires 2029-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Saul Patricia E.Director · Vice Chair
GrantCommon Stock 400 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000014 · wk-form4_1773350652.xml · nonDerivative · entry 2

Lotuff Patricia Saul · CIK 0001972629 · Director · Vice Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,833.641

F3 · shares: Represents additional restricted shares of Common Stock earned based on the achievement of performance criteria with respect to a performance period commencing on January 1, 2025 and ending on December 31, 2025. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Saul Patricia E.Director · Vice Chair
Exercise / conversionCommon Stock 800 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000014 · wk-form4_1773350652.xml · nonDerivative · entry 1

Lotuff Patricia Saul · CIK 0001972629 · Director · Vice Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,433.641

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents restricted shares of Common Stock. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

F2 · balance_after: Balance increased by July 31, 2025 Dividend Reinvestment Plan award, October 31, 2025 award, and January 31, 2026 award totaling 410.113 shares

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Friedman Joel AlbertExec VP, CAO & Treasurer
Exercise / conversionPerformance Shares · Derivative 400 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000012 · wk-form4_1773350638.xml · derivative · entry 15

Friedman Joel Albert · CIK 0001472420 · Exec VP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600

Underlying: Common Stock · 400 shares

Expires 2030-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Friedman Joel AlbertExec VP, CAO & Treasurer
Exercise / conversionPerformance Shares · Derivative 400 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000012 · wk-form4_1773350638.xml · derivative · entry 14

Friedman Joel Albert · CIK 0001472420 · Exec VP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,200

Underlying: Common Stock · 400 shares

Expires 2029-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Friedman Joel AlbertExec VP, CAO & Treasurer
GrantCommon Stock 400 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000012 · wk-form4_1773350638.xml · nonDerivative · entry 5

Friedman Joel Albert · CIK 0001472420 · Exec VP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,009.909

F4 · shares: Represents additional restricted shares of Common Stock earned based on the achievement of performance criteria with respect to a performance period commencing on January 1, 2025 and ending on December 31, 2025. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:24 UTC
Friedman Joel AlbertExec VP, CAO & Treasurer
Exercise / conversionCommon Stock 800 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000012 · wk-form4_1773350638.xml · nonDerivative · entry 4

Friedman Joel Albert · CIK 0001472420 · Exec VP, CAO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,609.909

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Represents restricted shares of Common Stock. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

F3 · balance_after: Balance increased by July 31, 2025 Dividend Reinvestment Plan award, October 31, 2025 award and January 31, 2026 award totaling 34.339 shares

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Godby LoriSenior Vice Pres.-Residential
Exercise / conversionPerformance Shares · Derivative 100 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000011 · wk-form4_1773350630.xml · derivative · entry 7

Godby Lori · CIK 0001851292 · Senior Vice Pres.-Residential

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400

Underlying: Common Stock · 100 shares

Expires 2030-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Godby LoriSenior Vice Pres.-Residential
Exercise / conversionPerformance Shares · Derivative 100 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000011 · wk-form4_1773350630.xml · derivative · entry 6

Godby Lori · CIK 0001851292 · Senior Vice Pres.-Residential

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300

Underlying: Common Stock · 100 shares

Expires 2029-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Godby LoriSenior Vice Pres.-Residential
GrantCommon Stock 100 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000011 · wk-form4_1773350630.xml · nonDerivative · entry 2

Godby Lori · CIK 0001851292 · Senior Vice Pres.-Residential

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,416

F2 · shares: Represents additional restricted shares of Common Stock earned based on the achievement of performance criteria with respect to a performance period commencing on January 1, 2025 and ending on December 31, 2025. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Godby LoriSenior Vice Pres.-Residential
Exercise / conversionCommon Stock 200 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000011 · wk-form4_1773350630.xml · nonDerivative · entry 1

Godby Lori · CIK 0001851292 · Senior Vice Pres.-Residential

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,316

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents restricted shares of Common Stock. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Laycock Willoughby B.Director · SVP-Res. Design/Mrkt Research
Exercise / conversionPerformance Shares · Derivative 100 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000010 · wk-form4_1773350620.xml · derivative · entry 16

Laycock Willoughby B. · CIK 0001771496 · Director · SVP-Res. Design/Mrkt Research

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400

Underlying: Common Stock · 100 shares

Expires 2030-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Laycock Willoughby B.Director · SVP-Res. Design/Mrkt Research
Exercise / conversionPerformance Shares · Derivative 100 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000010 · wk-form4_1773350620.xml · derivative · entry 15

Laycock Willoughby B. · CIK 0001771496 · Director · SVP-Res. Design/Mrkt Research

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300

Underlying: Common Stock · 100 shares

Expires 2029-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Laycock Willoughby B.Director · SVP-Res. Design/Mrkt Research
GrantCommon Stock 100 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000010 · wk-form4_1773350620.xml · nonDerivative · entry 3

Laycock Willoughby B. · CIK 0001771496 · Director · SVP-Res. Design/Mrkt Research

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,370.068

F2 · shares: Represents additional restricted shares of Common Stock earned based on the achievement of performance criteria with respect to a performance period commencing on January 1, 2025 and ending on December 31, 2025. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Laycock Willoughby B.Director · SVP-Res. Design/Mrkt Research
Exercise / conversionCommon Stock 200 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000010 · wk-form4_1773350620.xml · nonDerivative · entry 2

Laycock Willoughby B. · CIK 0001771496 · Director · SVP-Res. Design/Mrkt Research

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,270.068

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents restricted shares of Common Stock. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Friedlis Zachary MaxwellSr. VP-Director of Leasing
Exercise / conversionPerformance Shares · Derivative 300 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000009 · wk-form4_1773350612.xml · derivative · entry 5

Friedlis Zachary Maxwell · CIK 0002008933 · Sr. VP-Director of Leasing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,200

Underlying: Common Stock · 300 shares

Expires 2030-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Friedlis Zachary MaxwellSr. VP-Director of Leasing
Exercise / conversionPerformance Shares · Derivative 300 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000009 · wk-form4_1773350612.xml · derivative · entry 4

Friedlis Zachary Maxwell · CIK 0002008933 · Sr. VP-Director of Leasing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900

Underlying: Common Stock · 300 shares

Expires 2029-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Friedlis Zachary MaxwellSr. VP-Director of Leasing
GrantCommon Stock 300 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000009 · wk-form4_1773350612.xml · nonDerivative · entry 3

Friedlis Zachary Maxwell · CIK 0002008933 · Sr. VP-Director of Leasing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,206.093

F3 · shares: Represents additional restricted shares of Common Stock earned based on the achievement of performance criteria with respect to a performance period commencing on January 1, 2025 and ending on December 31, 2025. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Friedlis Zachary MaxwellSr. VP-Director of Leasing
Exercise / conversionCommon Stock 600 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000009 · wk-form4_1773350612.xml · nonDerivative · entry 2

Friedlis Zachary Maxwell · CIK 0002008933 · Sr. VP-Director of Leasing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,906.093

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents restricted shares of Common Stock. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

F2 · balance_after: Balance increased by July 31, 2025 Dividend Reinvestment Plan award, October 31, 2025 award and January 31, 2026 award totaling 61.074 shares

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Heard Carlos LawrenceSenior Vice President & CFO
Exercise / conversionPerformance Shares · Derivative 400 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000008 · wk-form4_1773350602.xml · derivative · entry 8

Heard Carlos Lawrence · CIK 0001849267 · Senior Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600

Underlying: Common Stock · 400 shares

Expires 2030-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Heard Carlos LawrenceSenior Vice President & CFO
Exercise / conversionPerformance Shares · Derivative 400 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000008 · wk-form4_1773350602.xml · derivative · entry 7

Heard Carlos Lawrence · CIK 0001849267 · Senior Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,200

Underlying: Common Stock · 400 shares

Expires 2029-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Heard Carlos LawrenceSenior Vice President & CFO
GrantCommon Stock 400 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000008 · wk-form4_1773350602.xml · nonDerivative · entry 3

Heard Carlos Lawrence · CIK 0001849267 · Senior Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,930.835

F3 · shares: Represents additional restricted shares of Common Stock earned based on the achievement of performance criteria with respect to a performance period commencing on January 1, 2025 and ending on December 31, 2025. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

Read SEC document
March 11, 2026 Filed Mar 12, 2026 21:23 UTC
Heard Carlos LawrenceSenior Vice President & CFO
Exercise / conversionCommon Stock 800 $0.00 $0.00
Disclosure

SEC source: 0000907254-26-000008 · wk-form4_1773350602.xml · nonDerivative · entry 2

Heard Carlos Lawrence · CIK 0001849267 · Senior Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,530.835

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents restricted shares of Common Stock. Fifty percent (50%) of the shares vest on May 17, 2029, and the remaining fifty percent (50%) vest on May 9, 2030, subject to the reporting persons continued employment through the applicable vesting dates.

F2 · balance_after: Balance increased by January 31, 2026 Dividend Reinvestment Plan award of 5.659 shares.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 18:19 UTC Exercise / conversionPhantom Stock · Derivative 3,690 $31.50 $116,235.00
Disclosure

SEC source: 0001216742-26-000002 · wk-form4_1767723566.xml · derivative · entry 10

CLANCY GEORGE PATRICK JR · CIK 0001216742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,689.856

Underlying: Common Stock · 3,690 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan.

F2 · derivative.exercise_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

F2 · derivative.expiration_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

Read SEC document
January 05, 2026 Filed Jan 6, 2026 18:19 UTC Exercise / conversionCommon Stock 3,690 $31.50 $116,235.00
Disclosure

SEC source: 0001216742-26-000002 · wk-form4_1767723566.xml · nonDerivative · entry 1

CLANCY GEORGE PATRICK JR · CIK 0001216742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,605

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 20:13 UTC GrantPhantom Stock · Derivative 634.316 $31.53 $19,999.98
Disclosure

SEC source: 0001216742-26-000001 · wk-form4_1767644004.xml · derivative · entry 10

CLANCY GEORGE PATRICK JR · CIK 0001216742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,379.856

Underlying: Common Stock · 634.316 shares

Expires not disclosed

F1 · derivative.exercise_price: New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan.

F2 · derivative.exercise_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

F2 · derivative.expiration_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

F3 · balance_after: Includes 135.486 shares awarded October 31, 2025 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.

Read SEC document
November 20, 2025 Filed Nov 20, 2025 19:13 UTC
Heard Carlos LawrenceSenior Vice President & CFO
PurchaseSeries D Preferred Stock 300 $20.55 $6,165.00
Disclosure

SEC source: 0001849267-25-000003 · wk-form4_1763666015.xml · nonDerivative · entry 2

Heard Carlos Lawrence · CIK 0001849267 · Senior Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Read SEC document
November 18, 2025 Filed Nov 18, 2025 20:59 UTC
Heard Carlos LawrenceSenior Vice President & CFO
PurchaseSeries D Preferred Stock 600 $20.35 $12,210.00
Disclosure

SEC source: 0001849267-25-000002 · wk-form4_1763499590.xml · nonDerivative · entry 4

Heard Carlos Lawrence · CIK 0001849267 · Senior Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,700

Read SEC document
November 17, 2025 Filed Nov 18, 2025 20:59 UTC
Heard Carlos LawrenceSenior Vice President & CFO
PurchaseSeries D Preferred Stock 600 $20.54 $12,324.00
Disclosure

SEC source: 0001849267-25-000002 · wk-form4_1763499590.xml · nonDerivative · entry 3

Heard Carlos Lawrence · CIK 0001849267 · Senior Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,100

Read SEC document
November 14, 2025 Filed Nov 18, 2025 20:59 UTC
Heard Carlos LawrenceSenior Vice President & CFO
PurchaseSeries D Preferred Stock 450 $20.50 $9,225.00
Disclosure

SEC source: 0001849267-25-000002 · wk-form4_1763499590.xml · nonDerivative · entry 2

Heard Carlos Lawrence · CIK 0001849267 · Senior Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Read SEC document
November 13, 2025 Filed Nov 13, 2025 21:54 UTC
Heard Carlos LawrenceSenior Vice President & CFO
PurchaseSeries D Preferred Stock 450 $20.60 $9,270.00
Disclosure

SEC source: 0000907254-25-000110 · wk-form4_1763070896.xml · nonDerivative · entry 4

Heard Carlos Lawrence · CIK 0001849267 · Senior Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,050

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:54 UTC
Heard Carlos LawrenceSenior Vice President & CFO
PurchaseSeries D Preferred Stock 450 $20.70 $9,315.00
Disclosure

SEC source: 0000907254-25-000110 · wk-form4_1763070896.xml · nonDerivative · entry 3

Heard Carlos Lawrence · CIK 0001849267 · Senior Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,600

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:54 UTC
Collich JohnSr. VP, Chief Acq. & Dev. Off.
PurchaseCommon Stock 2,000 $29.99 $59,986.60
Disclosure

SEC source: 0000907254-25-000109 · wk-form4_1763070888.xml · nonDerivative · entry 4

Collich John · CIK 0001228472 · Sr. VP, Chief Acq. & Dev. Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,259.62

F3 · balance_after: Balance increased by July 31, 2025 Dividend Reinvestment Plan award and October 31, 2025 award totaling 1,683.62 shares.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 21:53 UTC
Pearson David ToddDirector · President & COO
PurchaseCommon Stock 3,348 $29.86 $99,977.98
Disclosure

SEC source: 0001804456-25-000003 · wk-form4_1763070820.xml · nonDerivative · entry 2

Pearson David Todd · CIK 0001804456 · Director · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,566.916

F2 · balance_after: Balance increased by October 31, 2025 Dividend Reinvestment Plan award of 54.416 shares.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 21:54 UTC
Heard Carlos LawrenceSenior Vice President & CFO
PurchaseSeries D Preferred Stock 450 $20.85 $9,382.50
Disclosure

SEC source: 0000907254-25-000110 · wk-form4_1763070896.xml · nonDerivative · entry 2

Heard Carlos Lawrence · CIK 0001849267 · Senior Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,150

Read SEC document
October 01, 2025 Filed Oct 1, 2025 18:49 UTC GrantPhantom Stock · Derivative 627.55 $31.87 $20,000.02
Disclosure

SEC source: 0001216742-25-000004 · wk-form4_1759344548.xml · derivative · entry 10

CLANCY GEORGE PATRICK JR · CIK 0001216742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,610.054

Underlying: Common Stock · 627.55 shares

Expires not disclosed

F1 · derivative.exercise_price: New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan.

F2 · derivative.exercise_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

F2 · derivative.expiration_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

F3 · balance_after: Includes 110.643 shares awarded July 31, 2025 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.

Read SEC document
October 01, 2025 Filed Oct 1, 2025 18:47 UTC GrantPhantom Stock · Derivative 509.884 $31.87 $16,250.00
Disclosure

SEC source: 0001144844-25-000004 · wk-form4_1759344463.xml · derivative · entry 10

CHAPOTON JOHN E · CIK 0001144844 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,955.498

Underlying: Common Stock · 509.884 shares

Expires not disclosed

F1 · derivative.exercise_price: New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan.

F2 · derivative.exercise_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

F2 · derivative.expiration_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

F3 · balance_after: Includes 526.084 shares awarded July 31, 2025 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.

Read SEC document
July 01, 2025 Filed Jul 1, 2025 22:53 UTC GrantPhantom Stock · Derivative 475.981 $34.14 $16,249.99
Disclosure

SEC source: 0000907254-25-000091 · wk-form4_1751410405.xml · derivative · entry 10

CHAPOTON JOHN E · CIK 0001144844 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,919.53

Underlying: Common Stock · 475.981 shares

Expires not disclosed

F1 · derivative.exercise_price: New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan.

F2 · derivative.exercise_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

F2 · derivative.expiration_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

Read SEC document
July 01, 2025 Filed Jul 1, 2025 22:53 UTC GrantPhantom Stock · Derivative 585.823 $34.14 $20,000.00
Disclosure

SEC source: 0000907254-25-000090 · wk-form4_1751410394.xml · derivative · entry 10

CLANCY GEORGE PATRICK JR · CIK 0001216742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,871.861

Underlying: Common Stock · 585.823 shares

Expires not disclosed

F1 · derivative.exercise_price: New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan.

F2 · derivative.exercise_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

F2 · derivative.expiration_date: The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.

Read SEC document
May 21, 2025 Filed May 21, 2025 20:21 UTC
Pearson David ToddDirector · President & COO
PurchaseCommon Stock 1,362 $32.96 $44,891.52
Disclosure

SEC source: 0000907254-25-000086 · wk-form4_1747858900.xml · nonDerivative · entry 4

Pearson David Todd · CIK 0001804456 · Director · President & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,164.5

Read SEC document
May 21, 2025 Filed May 28, 2025 21:08 UTC
Guevara Bettina T.Exec. VP /Chf Legal & Adm Off
PurchaseCommon Stock 210 $33.00 $6,930.00
Disclosure

SEC source: 0000907254-25-000089 · wk-form4_1748466483.xml · nonDerivative · entry 1

Guevara Bettina T. · CIK 0002008664 · Exec. VP /Chf Legal & Adm Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,792

Read SEC document
May 20, 2025 Filed May 21, 2025 20:21 UTC GrantCommon Stock 46 $33.81 $1,555.26
Disclosure

SEC source: 0000907254-25-000083 · wk-form4_1747858863.xml · nonDerivative · entry 1

CLANCY GEORGE PATRICK JR · CIK 0001216742 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,915

F1 · shares: Shares acquired in an exempt transaction as dividend equivalents on filers restricted stock award, which vested on May 20, 2025.

Read SEC document
May 17, 2025 Filed May 21, 2025 20:22 UTC
Guevara Bettina T.Exec. VP /Chf Legal & Adm Off
GrantCommon Stock 22 $34.39 $756.58
Disclosure

SEC source: 0000907254-25-000088 · wk-form4_1747858925.xml · nonDerivative · entry 2

Guevara Bettina T. · CIK 0002008664 · Exec. VP /Chf Legal & Adm Off

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,582

F1 · shares: Shares acquired in an exempt transaction as dividend equivalents on filer's restricted stock award, which vested on May 17, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.